Listed below are confirmed speakers and their objectives for their session. For further details on speaker topics and timings click on the speakers name, this will direct you to their session on the relevant programme page.
Speakers will include:
Session 1 Title: Fifty Years of Resistance
Objectives of presentation:
- To describe the evolution of antibacterial resistance over the last
50 years
- To consider what went wrong
- To consider what happens next
Session 2 Title: CSI healthcare - examining the clues to HCAIs
Objectives of presentation:
- Describe infection surveillance, moving from the 20th to the 21st century
- Identify influences on surveillance in the present political and healthcare environment
- Suggest elements of healthcare-associated infections (HAI) surveillance for the coming years
Session 5 Title: Epidemiology in Practice
Objective of presentation:
- Outline the essential elements of an healthcare-associated infections (HAI) surveillance system
- Review the surveillance methodology used in NHSN, including the collection of numerator and denominator
data
- Describe the recently revised surveillance criteria for urinary tract infection
Session 3 Title: The cost of MRSA prevention-good value for money
Objectives of presentation:
- To outline the costs of MRSA infections to the health sector and beyond
- To discuss the realtive costs of MRSA prevention and and control measures
Session 4 Title: Decontamination in practice
Objectives of presentation:
- To review the current definition of decontamination, why it exists and the sources of guidance that
are available
- To assess the different requirements for decontamination and how these are achieved and monitored
- To explore the links between decontamination and infection prevention and to equip ICPs to know when
problems with decontamination are also problems with infection control.
Session 6 Title: New to infection prevention and control? River deep, mountain high ...does this
sound familiar within your new role? Top ten tips for survival
This workshop is designed for new infection control practitioners but people attending an IPS conference for
the first time will also benefit. It explores the value of professional networking and gives an insight into how
to go about it.
Session 7 Title: Making an Impact on Patient Safety - every single moment
Objectives of presentation:
- To describe and compare historical and current patient safety errors specifically related to hand hygiene
compliance
- To describe why the challenge of preventing harm due to lack of hand hygiene still exists in the 21st century
and to contrast the hand hygiene improvement movement with parallel initiatives which attempt to change
behaviour such as road safety and those associated with tackling high profile communicable diseases
- To explain and critique the current and potential simple, affordable and sustainable solutions to prevent these
errors, centred around improved hand hygiene performance at the right times - every single moment
Session 8 Title: From disasters to safe IV systems
Objectives of presentation:
- To demonstrate one means of investigating IV systems and evaluating the degree to which they are reliable
and or error prone
- To provide ICPs with an understanding of Human Error Theory when investigating serious IV incidents
- To provide ICPs with examples of how to optimise the safety and reliability of IV systems
Session 9 Title: MRSA in care homes - a reflection of hospitals or the community?
Objectives of presentation:
- To understand the scope of MRSA in the care home setting, the implications, and possible interventions
- To understand the implications of MRSA colonisation in care home residents
- To discuss possible interventions
Session 10 Title: Implementing a patient environment 'Hygiene care bundle'
- To identify high risk contact surfaces within the patient environment
- To understand the characteristics of the various surface types found in the patient environment and the ability
of microorganisms to penetrate, lodge and colonise these surfaces
- To present reserach data which demonstrates the safe and effective decontaminsation of these surface
types using novel dry steam vapour and microfibre healthcare tools
Session 11 Title: The pursuit for excellence during a global pandemic
We are now witnessing the evolution of the first infectious disease pandemic of the 21st century and it’s
having a galvanising effect on every person and every agency responsible for the delivery of healthcare.
Well-rehearsed pandemic preparedness action plans are now being rolled out to provide effective healthcare
during a turbulent period in which the infrastructures of both the National Health Service and civil society may
be tested and stressed. All healthcare practitioners needs to be confident that they can play their part in
ensuring the provision of clinically effective care to patients during this period while at the same time
protecting themselves and other patients from infection.
Pandemics are transformational; nothing is ever the same after they have come and gone and no one yet
knows the full impact and consequences this pandemic will have on our country and our world. As the
anticipated next pandemic wave approaches this autumn, the need for confidence, competence,
courage and excellence in infection prevention practice has never been greater.
Learning Objectives
1. Critically discuss the clinical infection prevention and control approaches in national and local pandemic
preparedness strategies
2. Consider the elements of personal, professional and clinical excellence in infection prevention practice
Session 12 Title: Leadership and the Professional ICN
Rosemary Kennedy is not only a tireless supporter of improved infection prevention practices but she is also
a widely acclaimed speaker on leadership. She believes passionately that we all have an opportunity to
learn from great leaders and take on leadership activities regardless of your role. It will be an inspiring
presentation.
Session 13 Title: Dr Thomas Latta Lecture - the father of infusion therapy
What is the link between cholera, saline therapy and IV therapy, you will have to attend the inaugural
Dr Thomas Latta Lecture to find out.
Session 14 Title: Why are Noroviruses such successful pathogens in healthcare settings? Studies of
norovirus infectivity, persistence and disinfection
Objectives of presentation:
- Review the epidemiology of norovirus infections and outbreaks
- Learn about the characteristics of noroviruses that allow them to be successful pathogens
- Review public health measures to prevent and control norovirus transmission
Session 16 Title: Blood, bones and bacteria - the diversity of a community intravenous therapy service
Objectives of presentation:
- To gain understanding of a community intravenous therapy service
- To To understand the development and expansion of community intravenous therapy service
- How the community intravenous therapy team achieves and maintain gold standard infection rates in
intravenous therapies
Specialist (Healthcare Associated Infection)
Session 17 Title: Developing Organisational Learning to Improve Practice
Objectives of presentation:
- Ensuring that key systems and processes are available to gain intelligence in an organisation
- Delivering improvement through organisational learning
- Evaluating the impact of orgaisational change based on learning
Session 18 Title: Fitness to practice - the road to competence
Objectives of presentation:
- Discuss the purpose and implications of core competencies in relation to Infection Prevention and
Control Practitioners
- Provide an overview of the review and development of the IPS core competencies
- Outline the process for the utilisation and evaluation of the new IPS core competencies
Session 19 Title: Aseptic non touch technique - consolidating the UK standard
Objectives of presentation:
- Delegates will be provided with an update of ANTT implementation across the UK
- The 'ANTT-effect' on HCAI will be discussed in light of findings to date
- Attendees will be introduced to the revised ANTT theory framework
Session 20 Title: Outbreak in a mental health facility - and now for something completely different!
Objectives of presentation:
- Attendees will learn about the difficulties of controlling an enteric outbreak on a mental health ward
- The attendee will be given some practical suggestions for controlling spread of an illness on a mental
health ward
- The speaker will share some of the lighter moments during this outbreak
Session 21 Title: Questioning practice - a practitioner's view
Objectives of presentation:
- To discuss the real world challenges of researching clinical practice
- To consider how practitioners' roles can be developed and supported to provide the evidence base
for infection prevention
Session 22 Title: Creating a business case - from start to finish
Objectives of presentation:
- To introduce practitioners to the concepts of a business case
- To look at a model of a business case - giving an example of how to use it
- To discuss the results
Session 23 Title: Exposing the truth about disinfectants
Objectives of presentation:
- Explain what an IC nurse should look for and what to ask a company when presented with a
disinfectant product
- Explain how to analyse the test data that disinfectants are subjected to
- Explain the regulations behind disinfectant use in the UK
- Consider criteria which might be used in selecting a product
Session 25 Title: Microbial biofilms - getting to the source of vascular catheter infections
At the end of this presentation the participant will be able to:
- Describe the formation and significance of biofilm on medical devices
- Explain the pathogenesis of vascular catheter-related infections
- Identify at least four critical strategies for the prevention of biofilm formation on the extraluminal and
intraluminal surfaces of vascular catheters
Session 26 Title: Fighting infection from the inside out
- Explain the roles of intra and extra-luminal pathways of infection, device colonization, biofilms fomation and
their role in CR-BSI
- Describe strategies to protect the intra-luminal pathway from colonisation and biofilm formation
- Consider how some medical devices actively protect against pathogens known to cause CR-BSI
Session 28 Title: Show me the proof - healthcare acquired infections in dentistry
Objectives of presentation:
- To update the risks of transmission of healthcare acquired infections via dental treatment
- To provide evidence of transmssion of infection in the dental surgery
- To outline procedures to minimise healthcare acquired infection during dental procedures
Session 29 Title: Is Carlsberg really the best lager in the world? - the evidence
Objectives of presentation:
- To critically appraise infection control evidence using current awareness of research methods
- To evaluate the evidence within peer reviewed literature using a framework identifying the key questions
to ask
- To utilise evidence to develop clinical practice
Session 40 Title: Universal screening for MRSA - Interim results from the NHSScotland pathfinder
project
Objectives of presentation:
- To describe the colonisation prevalence on admission to hospital and risk factors for MRSA colonisation
- To discuss organisational challenges arising from universal screening
- To overview the NHSScotland policy for MRSA screening
Dr John Bleasdale, Lead Clinician, Critical Care, City Hospital, Birmingham
Session 31 Title: Designing, using and evaluating checklists for the management of Influenza A
(H1N1) in clinical settings - your questions and more, answered
Session 32 Title: Heretics and Lunatics in infection control
Objectives of presentation:
- Identify characters in the history of infection control who were initially thought to be heretical or lunatics for
their ideas
- Follow the evolution of "common knowledge" that brought their ideas from heresy to acceptance and
eventually to unquestioned wisdom
- Identify modern day characters with heretical views and how they might impact the profession of infection
prevention and control
Nurse Specialist, Infection Prevention and Control, Glan Clwyd Hospital
Session 33 Title: Designing out infection in a hospital environment
Objectives of presentation:
- To describe how infection prevention nurses can influence the development of new equipment
- To demonstrate the outcome of an evaluation of a new piece of equipment from the ‘Design Bugs Out’
competitions
- To outline how it is possible to get involved in product development and the impact it could have in
reducing infections in your hospitals’
Session 36 Title: Patient Safety First campaign
Objectives of presentation:
- To inform attendees about the Patient Safety First Campaign
- To highlight the interventions aimed at reducing hospital associated infection
- To demonstrate a quality improvement approach to reducing hospital associated infection
Session 37 Title: World Class Commissioning for World Class Infection Prevention and Control
Objectives of presenation:
- To provide a background into the commissioning role of PCTs
- To provide delagates with an overview of commissioning in respect of IPC
- To provide an insight into how commissioning for IPC needs to look in the future
Session 38 Title: When things go wrong - Corporate Manslaughter
Objectives of presentation:
- To provide an overview of the Corporate Manslaughter Act 2007
- Explain what the Act means for NHS Organisations and its employees
- Discuss the new offence (with particular reference to infection prevention), ways to avoid liability and the
penalties imposed
Session 39 Title: Transparency - the imperative of an open and honest dialogue, The University of
Michigan's malpractic claims experience
Objectives of presenation:
- Describe the University of Michigan's claims management model
- Identify 3 claims management principles
- Identify the benefits of a principled approach
Session 39a Title: An Inspector Calls: Care Quality Commission and HCAI Regulation
Objectives of presenation:
- An overview of current HCAI regulation
- CQC HCAI inspection programme
- What the future holds
Session 39b Title: Ward Isolation Facilities in an Acute setting (HBN4)- An update
Objectives of presenation:
- To explain how the Possitive Pressure Ventilated Lobby (PPVL) concept can provide a universal
solution for a ward isolation facility
- To review the research and development underlying the PPVL concept
- To illustrate the practical application of the PPVL concept in a typical hospital
Session 40 Title: Where are we with MRSA screening in England?
Objectives of presenation:
- To describe the colonisation prevalence on admission to hospital and risk factors for MRSA colonisation
- To discuss organisational challenges arising from universal screening
- To overview the NHSScotland policy for MRSA screening
Session 41 Title: Hot off the press - a review of the evidence
Objectives of presenation:
- To discuss the latest evidence on the prevention and control of selected healthcare-associated
infections (HAIs).
- To illustrate how introduction of evidence-based interventions can prevent a much larger proportion of
HAIs then previously estimated.
- To describe these HAI prevention bundles and illustrate that they are a combination of relatively
inexpensive technology and common sense (no technology).
- To challenge the infection control world to immediately implement these evidence-based HAI prevention
bundles, rather then be forced to by HAI prevention activists and/or governments.
Session 42 Title: Moving on from audit - Quality improvement tools for infection prevention
Objective of presentation:
- Describe the contribution of quality improvement methods to the practice of infection prevention and control
- Demonstrate the need for appropriate process measurement tools in order to drive improvement
- Introduce the IPS Quality Improvement Tools and describe their development
For all other details please contact Stacy Martin, IPS events on 01506 811077 or email ips@fitwise.co.uk